![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Xueguang Lu, Lei Miao, Wenting Gao, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 556
Open Access | Times Cited: 142
Xueguang Lu, Lei Miao, Wenting Gao, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 556
Open Access | Times Cited: 142
Showing 1-25 of 142 citing articles:
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 293
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 293
Tailoring Materials for Modulation of Macrophage Fate
Jinhua Li, Xinquan Jiang, Hongjun Li, et al.
Advanced Materials (2021) Vol. 33, Iss. 12
Open Access | Times Cited: 252
Jinhua Li, Xinquan Jiang, Hongjun Li, et al.
Advanced Materials (2021) Vol. 33, Iss. 12
Open Access | Times Cited: 252
The cGAS–STING pathway and cancer
Natasha Samson, Andrea Ablasser
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1452-1463
Closed Access | Times Cited: 249
Natasha Samson, Andrea Ablasser
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1452-1463
Closed Access | Times Cited: 249
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 180
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 180
Selective STING stimulation in dendritic cells primes antitumor T cell responses
Bakhos Jneid, Aurore Bochnakian, Caroline Hoffmann, et al.
Science Immunology (2023) Vol. 8, Iss. 79
Open Access | Times Cited: 65
Bakhos Jneid, Aurore Bochnakian, Caroline Hoffmann, et al.
Science Immunology (2023) Vol. 8, Iss. 79
Open Access | Times Cited: 65
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Materials engineering strategies for cancer vaccine adjuvant development
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 47
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 47
Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 40
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 40
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance
Audrey Lee, Katharine Floyd, Shengyang Wu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 41-53
Closed Access | Times Cited: 38
Audrey Lee, Katharine Floyd, Shengyang Wu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 41-53
Closed Access | Times Cited: 38
Long-acting PLGA microspheres: Advances in excipient and product analysis toward improved product understanding
Bo Wan, Quanying Bao, Diane J. Burgess
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114857-114857
Closed Access | Times Cited: 37
Bo Wan, Quanying Bao, Diane J. Burgess
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114857-114857
Closed Access | Times Cited: 37
Roll-to-roll, high-resolution 3D printing of shape-specific particles
Jason M. Kronenfeld, Lukas Rother, Max A. Saccone, et al.
Nature (2024) Vol. 627, Iss. 8003, pp. 306-312
Open Access | Times Cited: 24
Jason M. Kronenfeld, Lukas Rother, Max A. Saccone, et al.
Nature (2024) Vol. 627, Iss. 8003, pp. 306-312
Open Access | Times Cited: 24
Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years
Neha Kapate, John R. Clegg, Samir Mitragotri
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113807-113807
Open Access | Times Cited: 88
Neha Kapate, John R. Clegg, Samir Mitragotri
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113807-113807
Open Access | Times Cited: 88
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed, Fang‐Ming Chen, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 30
Open Access | Times Cited: 85
Madiha Saeed, Fang‐Ming Chen, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 30
Open Access | Times Cited: 85
Polymeric microneedle‐mediated sustained release systems: Design strategies and promising applications for drug delivery
Yang Li, Yao Yang, Hongzhong Chen, et al.
Asian Journal of Pharmaceutical Sciences (2021) Vol. 17, Iss. 1, pp. 70-86
Open Access | Times Cited: 56
Yang Li, Yao Yang, Hongzhong Chen, et al.
Asian Journal of Pharmaceutical Sciences (2021) Vol. 17, Iss. 1, pp. 70-86
Open Access | Times Cited: 56
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
DaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Advanced Materials (2021) Vol. 33, Iss. 27
Closed Access | Times Cited: 55
DaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Advanced Materials (2021) Vol. 33, Iss. 27
Closed Access | Times Cited: 55
Sustained delivery approaches to improving adaptive immune responses
Ben S. Ou, Olivia M. Saouaf, Julie Baillet, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114401-114401
Open Access | Times Cited: 54
Ben S. Ou, Olivia M. Saouaf, Julie Baillet, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114401-114401
Open Access | Times Cited: 54
Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application
Héloïse Ragelle, Sima Rahimian, Elia A. Guzzi, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113990-113990
Closed Access | Times Cited: 53
Héloïse Ragelle, Sima Rahimian, Elia A. Guzzi, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113990-113990
Closed Access | Times Cited: 53
Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation
Zichao Luo, Xiuqi Liang, Tao He, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 36, pp. 16366-16377
Closed Access | Times Cited: 48
Zichao Luo, Xiuqi Liang, Tao He, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 36, pp. 16366-16377
Closed Access | Times Cited: 48
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
Ting Su, Furong Cheng, Jialong Qi, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 47
Ting Su, Furong Cheng, Jialong Qi, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 47
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 46
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 46
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
Huan Zheng, Beibei Guo, Xinyun Qiu, et al.
Bioactive Materials (2022) Vol. 16, pp. 1-11
Open Access | Times Cited: 44
Huan Zheng, Beibei Guo, Xinyun Qiu, et al.
Bioactive Materials (2022) Vol. 16, pp. 1-11
Open Access | Times Cited: 44
Current trends in PLGA based long-acting injectable products: The industry perspective
Omkara Swami Muddineti, Abdelwahab Omri
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 5, pp. 559-576
Closed Access | Times Cited: 38
Omkara Swami Muddineti, Abdelwahab Omri
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 5, pp. 559-576
Closed Access | Times Cited: 38
LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis
Sipeng Lin, Zhenkang Wen, Shixun Li, et al.
Acta Biomaterialia (2022) Vol. 142, pp. 345-360
Closed Access | Times Cited: 35
Sipeng Lin, Zhenkang Wen, Shixun Li, et al.
Acta Biomaterialia (2022) Vol. 142, pp. 345-360
Closed Access | Times Cited: 35
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 30
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 30
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 26
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 26